Navigation Links
Intercept Pharmaceuticals Names Dr. Luciano Adorini Chief Scientific Officer
Date:1/3/2008

NEW YORK, Jan. 3 /PRNewswire/-- Intercept Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company developing therapeutics for the treatment of chronic fibrotic and metabolic diseases, today announced the appointment of Luciano Adorini, M.D., to the newly created position of Chief Scientific Officer. Dr. Adorini brings over 20 years of experience in therapeutic research and development, recently serving as Chief Scientific Officer at BioXell (SWX: BXLN), a biopharmaceutical company which he co-founded.

Mark Pruzanski, M.D., Founder, President and CEO of Intercept Pharmaceuticals, commented, "Luciano's proven R&D leadership will be invaluable as we continue to advance our pipeline of first-in-class compounds and expand our focus beyond chronic liver diseases to other indications involving progressive organ damage that results from some combination of chronic inflammation, fibrosis and metabolic dysfunction."

During Dr. Adorini's tenure at BioXell, he was responsible for advancing a broad pipeline of products in multiple disease indications. Prior to this, he served as Associate Director of Roche Milano Ricerche, where he contributed to the development of several drugs. Earlier in his career, Dr. Adorini was research director of a unit at the Preclinical Research Center, Sandoz Pharma, Ltd., in Basel.

Dr. Adorini has authored over 240 journal articles and other scientific publications, becoming a highly cited researcher in Immunology, with a focus on immunosuppressive and immunoregulatory mechanisms in the treatment of inflammatory and autoimmune diseases. He is a board member of a number of peer-reviewed publications and is currently serving as president of the Italian Society of Immunology, Clinical Immunology and Allergology. Dr. Adorini received his M.D. degree from the Medical School of Padova University and conducted postdoctoral studies at the University of California at Los Angeles.

About Intercept Pharmaceuticals '/>"/>

SOURCE Intercept Pharmaceuticals, Inc.
Copyright©2008 PR Newswire.
All rights reserved

1

GOOD

Page: 1 2

Related biology technology :

1. Vion Pharmaceuticals Pays Interest on 7.75% Convertible Senior Notes
2. China Biopharmaceuticals Holdings Announces Second Quarter 2007 Financial Results
3. Vion Pharmaceuticals Completes Accrual of 85 Patients to its Pivotal Phase II Trial of Cloretazine(R) (VNP40101M) in Elderly AML
4. XTL Biopharmaceuticals Announces Financial Results for the Six Months Ended June 30, 2007
5. Cadence Pharmaceuticals Reports Second Quarter 2007 Financial Results
6. Nabi Biopharmaceuticals to Present at Upcoming Industry Conferences
7. Anadys Pharmaceuticals Appoints Steve Worland, Ph.D. as President and Chief Executive Officer
8. Poniard Pharmaceuticals Announces Participation in Upcoming Conferences
9. NovaQuest Advances Virtual Development Model With Strategic Investment in TOPIGEN Pharmaceuticals
10. Drug Royalty Corporation (DRC) Announces Acquisition Regarding PEG-INTRON(R) From Enzon Pharmaceuticals, Inc. (ENZN)
11. Sunesis Pharmaceuticals Announces Reorganization to Focus Resources and Build Value in Clinical-Stage Programs
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/5/2008)...ring industry-leading event September 10 - 11, ...URN HILLS, Mich., Sept. 5 /- Plexus S...software for the medical manufacturing,enterprise,...gy Conference,September 10-11, 2008 at the San Jos..., (Logo: http://www.newscom.com/cgi-bin/prnh/200...
(Date:9/5/2008)...ember 5 /- The 33rd ESMO Congress,in ...gy, serves as a,meeting place for medical oncologi...th colleagues from other disciplines., The Congre...interaction, a teaching ground, and a place to dis... cancer research in Europe, the training of young,...
(Date:9/5/2008)...- BioSpecifics,Technologies...ical company,developing first in class collagenase...d an agreement to significantly improve the deal t... Peyronie,s disease by buying down its,future roya...oSpecifics has modified its previously announced a...
(Date:9/4/2008)... 4 /- MedQuist Inc.,(Nasdaq...ors has elected John,F. Jastrem, Colin J. O,Brien,...tember 4, 2008. Prior to the election of the new d... of the board from seven to 10 members., Accordin...a, "We are,pleased to have this opportunity to fur...
Breaking Biology Technology:Plexus Systems, Inc. to Exhibit at BIOMEDevice Medical Technology Conference 233rd ESMO Congress in Stockholm, 12-16 September 2008 233rd ESMO Congress in Stockholm, 12-16 September 2008 333rd ESMO Congress in Stockholm, 12-16 September 2008 433rd ESMO Congress in Stockholm, 12-16 September 2008 5BioSpecifics Technologies Corp. Buys Down Royalties for Peyronie's Disease 2MedQuist Announces Additions to Board of Directors 2MedQuist Announces Additions to Board of Directors 3
...Scanner 3000 , New Advances in Scanner Desi...mic Range , , , The Af...oundation for continued evolution of the GeneChip ...m, supporting continued feature size reduction for... of microarray-based products. The Affymetrix Gene...
...s Damaskinos a , Arthur E. Dixon a and Lucy E. J...., A12-550 Parkside Dr., Waterloo, Ontario N2L 5V4,...d Laurier University, 75 University Ave. W., Water... ABSTRACT , Conventional widefield light...been indispensable for pathology and drug discover...
...d Mass Spectrometry Application Report , K...Deca XP Plus Equine serum Acepromazine , ...n Jose, CA USA , Wayne Skinner and S... Introduction , Acepromazine is w... tranquilizer to better facilitate handling of the...
...d Mass Spectrometry Application Note , Key...antum Discovery Enhanced Mass- Resolution , ...ry Tucker 1 , and Walter Korfmacher 1 , ...inetics, Schering-Plough Research Institute, Kenil...omerset, NJ, USA , Overview , ...
Other Biology Technology:The Affymetrix GeneChip Scanner 3000, New Advances in Scanner Design for Superior Performance, Reliability, and Dynamic Range 2The Affymetrix GeneChip Scanner 3000, New Advances in Scanner Design for Superior Performance, Reliability, and Dynamic Range 3The Affymetrix GeneChip Scanner 3000, New Advances in Scanner Design for Superior Performance, Reliability, and Dynamic Range 4The Affymetrix GeneChip Scanner 3000, New Advances in Scanner Design for Superior Performance, Reliability, and Dynamic Range 5The Affymetrix GeneChip Scanner 3000, New Advances in Scanner Design for Superior Performance, Reliability, and Dynamic Range 6The Affymetrix GeneChip Scanner 3000, New Advances in Scanner Design for Superior Performance, Reliability, and Dynamic Range 7The Affymetrix GeneChip Scanner 3000, New Advances in Scanner Design for Superior Performance, Reliability, and Dynamic Range 8The Affymetrix GeneChip Scanner 3000, New Advances in Scanner Design for Superior Performance, Reliability, and Dynamic Range 9The Affymetrix GeneChip Scanner 3000, New Advances in Scanner Design for Superior Performance, Reliability, and Dynamic Range 10A new wide field-of-view confocal imaging system and its applications in drug discovery and pathology 2A new wide field-of-view confocal imaging system and its applications in drug discovery and pathology 3A new wide field-of-view confocal imaging system and its applications in drug discovery and pathology 4A new wide field-of-view confocal imaging system and its applications in drug discovery and pathology 5A new wide field-of-view confocal imaging system and its applications in drug discovery and pathology 6A new wide field-of-view confocal imaging system and its applications in drug discovery and pathology 7A new wide field-of-view confocal imaging system and its applications in drug discovery and pathology 8A new wide field-of-view confocal imaging system and its applications in drug discovery and pathology 9A new wide field-of-view confocal imaging system and its applications in drug discovery and pathology 10A new wide field-of-view confocal imaging system and its applications in drug discovery and pathology 11A new wide field-of-view confocal imaging system and its applications in drug discovery and pathology 12A new wide field-of-view confocal imaging system and its applications in drug discovery and pathology 13A new wide field-of-view confocal imaging system and its applications in drug discovery and pathology 14A new wide field-of-view confocal imaging system and its applications in drug discovery and pathology 15A new wide field-of-view confocal imaging system and its applications in drug discovery and pathology 16A new wide field-of-view confocal imaging system and its applications in drug discovery and pathology 17A new wide field-of-view confocal imaging system and its applications in drug discovery and pathology 18A new wide field-of-view confocal imaging system and its applications in drug discovery and pathology 19A new wide field-of-view confocal imaging system and its applications in drug discovery and pathology 20A new wide field-of-view confocal imaging system and its applications in drug discovery and pathology 21A new wide field-of-view confocal imaging system and its applications in drug discovery and pathology 22A new wide field-of-view confocal imaging system and its applications in drug discovery and pathology 23A new wide field-of-view confocal imaging system and its applications in drug discovery and pathology 24A new wide field-of-view confocal imaging system and its applications in drug discovery and pathology 25A new wide field-of-view confocal imaging system and its applications in drug discovery and pathology 26A new wide field-of-view confocal imaging system and its applications in drug discovery and pathology 27
(Date:9/5/2008)...ulations of wild animals face the challenge of sur...ial College London and Universit Claude Bernard Ly...sland off the west coast of Scotland responds to t...ailability and the unpredictability of winter stor...vealed, "When times are good and food is plentiful...
(Date:9/5/2008)...cksburg, Va. -- Innovative work on a new type of h...ssistant professor of mechanical engineering at Vi... Early Career Development (CAREER) award of $400,0... development of specific models and experiments to...with a stent that has a unique type of in situ pol...
(Date:9/5/2008)...ess release is available in French and Spanish ...ment of Nutrition and Bromatology and Department...da have carried out a study in which they have re...e university population who follows Ramadan. , A...time macronutrient consumption levels are not appr...
(Date:9/4/2008)...g, 5 September 2008 Even scientists define ,a gen...se that the media also have various ways of framin...appearing in the October 2008 issue of EMBO repor...e analysis of 300 articles in British and Norwegia...Mail from the UK; and Aftenposten, Dagbladet, and ...
Breaking Biology News(10 mins):Goulbourne earns NSF award to research heart stent sensors 2Goulbourne earns NSF award to research heart stent sensors 3Nutritionists of the UGR suggest diet improvements during Ramadan 2What is a gene? 2More Than 78 000 are Dead and Millions are Homeless After Cyclone Nargis Swept Through Myanmar 20722 1More Than 78 000 are Dead and Millions are Homeless After Cyclone Nargis Swept Through Myanmar 20722 2PROMACTA 28R 29 28eltrombopag 29 RECEIVES UNANIMOUS RECOMMENDATION BY FDA ADVISORY PANEL 20720 1PROMACTA 28R 29 28eltrombopag 29 RECEIVES UNANIMOUS RECOMMENDATION BY FDA ADVISORY PANEL 20720 2PROMACTA 28R 29 28eltrombopag 29 RECEIVES UNANIMOUS RECOMMENDATION BY FDA ADVISORY PANEL 20720 3PROMACTA 28R 29 28eltrombopag 29 RECEIVES UNANIMOUS RECOMMENDATION BY FDA ADVISORY PANEL 20720 4MDwise Enrollment Exceeds 300 000 Members 20718 1MDwise Enrollment Exceeds 300 000 Members 20718 2EPA Approves XDS CALUX 28R 29 as Alternate Dioxin Test Method 4435 2245 1EPA Approves XDS CALUX 28R 29 as Alternate Dioxin Test Method 4435 2245 2
...ive project with implications,for malaria vaccine ...mics and gene expression studies to trace how mala...move between their hosts and insect,vectors.,That ...ing researchers,understand when different genes sw...ugh seven different life stages. In turn, that,mol...
...nal team of scientists has used gene therapy in tw...e normal movements in monkeys and rats with a drug...rch, detailed online in the scientific publication...ly describes one strategy to halt Parkinson,s dise... devastating side effects that occur when treating...
...Library of Medicine, a part of the National Instit...election from the papers of one of the twentieth c...s Profiles in Science Web site. , ,Don,t miss Cri...test collection on Profiles in Science represents ... of Medicine and the Wellcome Library for the Hist...
...rted last week reveal how an,evolutionary innovati...species has given rise to a deep-seated dependency...ulations.,The new work illustrates how genetic exc...n give rise to a system of interdependence at a,hi..., the production of,worker ants for both species. ...
Other Biology News:Scientists reveal molecular secrets of the malaria parasite 2Scientists reveal molecular secrets of the malaria parasite 3Gene Therapy For Parkinson's Disease Moves Forward In Animals 2Gene Therapy For Parkinson's Disease Moves Forward In Animals 3Gene Therapy For Parkinson's Disease Moves Forward In Animals 4Papers of DNA Pioneer and Nobel Laureate Francis Crick Added to National Library of Medicine’s Profiles in Science Web Site 2Papers of DNA Pioneer and Nobel Laureate Francis Crick Added to National Library of Medicine’s Profiles in Science Web Site 3Ants Genetic Engineering Leads To Species Interdependency 2
This buffer is Specifically formulated to be used with Endogen's Poly-HRP Streptavidin
...ice-coil scanning and positioning system is design... positioned or scanned with high velocity and high...ompared to micropositioners with conventional lead...iven by an integrated, non-contact, zero-friction,...
... Synthesis and Labeling Kit generates labeled cDNA...First unmodified cDNA is made via a reverse transc...mer. Unlike other methods, there are no unnatural ...tion reaction. This unmodified cDNA is then labele...
...roducts feature a dual strength adhesive system wh...er use. The adhesives on either side of the frame ... to the glass has an easy release adhesive whereas... a stronger bond. This means that when the coversl...
Biology Products: